Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01302405
Title Safety and Efficacy Study of PRI-724 in Subjects With Advanced Solid Tumors
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Prism Pharma Co., Ltd.
Indications

Advanced Solid Tumor

Therapies

PRI-724

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.